(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without cirrhosis ...
Jul 25, 2015
0
21
Researchers at Rutgers and UMDNJ-Robert Wood Johnson Medical School have determined the structure of a protein that is the first line of defense in fighting viral infections including influenza, hepatitis C, West Nile, rabies, ...
Sep 29, 2011
0
0
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
Jan 31, 2012
0
0
In HIV-infected patients receiving antiretroviral therapy (ART), chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is associated with an increased risk for non-Hodgkin's lymphoma. The findings are published ...
Oct 17, 2016
0
0
More than 90,000 people in the United States are awaiting kidney transplants, with wait-times that can be five, seven, even 10 or more years, but new research from a team in the Perelman School of Medicine at the University ...
Sep 1, 2020
0
28
European surveillance data show a 10 percent decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union ...
Apr 3, 2019
0
2
Researchers at The Miriam Hospital demonstrated a practical strategy for regularly screening HIV-infected patients for acute hepatitis C virus infection (HCV), a "silent epidemic" that is rising undetected in this population ...
Oct 18, 2011
0
0
In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of ...
Mar 5, 2018
0
41
A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using the accessible care ...
Mar 24, 2022
0
0
A longitudinal cohort study of persons with a history of injection drug use has found that more people who inject drugs (PWID) are receiving Hepatitis C virus (HCV) treatment, which is associated with significant reductions ...
Jul 11, 2022
0
11
